The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients

Vaccine

Volumn 22, Issue 29-30, 2004, Pages 3963-3967

  Kara, Ismail Hamdi ^a   Yilmaz, Mehmet Emin ^a   Suner, Ali ^a   Kadiroglu, Ali Kemal ^a   Isikoglu, Bunyamin ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hemodialysis; Hepatitis B; Nutritional status; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; RECOMBINANT HEPATITIS B VACCINE; SERUM ALBUMIN;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELTOID MUSCLE; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROCONVERSION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; COHORT STUDIES; FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS C ANTIBODIES; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SEX FACTORS; VACCINES, SYNTHETIC;

EID: 4444235487     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.04.001     Document Type: Article

References (31)

1. Tokars J.I., Miller E.R., Alter M.J., Arduino M.J. National surveillance of dialysis associated diseases in the United States, 1995. ASAIO J. 44(1):1998;98-107
2. Chateneud L., Jungers P., Descamps-Latsha B. Immunological consideration of the uremic and dialysed patient. Kidney Int. 45(Suppl):1994;S92-S96
3. Cendoroglo Neto M., Draibe S.A., Silva A.E., Ferraz M.L., Granato C., Pereira C.A., et al. Incidence and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol. Dial. Transplant. 10:1995;240-246
4. Drachman R., Isacsohn M., Rudensky B., Drukker A. Vaccination against hepatitis B in children and adolescent patients on dialysis. Nephrol. Dial. Transplant. 4:1989;372-374
5. Ozener C., Fak A.S., Avsar E., Cinar S., Lawrence R., Akoglu E. The effect of alpha interferon therapy and short interval intradermal administration on response to hepatitis B vaccine in haemodialysis patients. Nephrol. Dial. Transplant. 14:1999;1339-1340
6. Center for Disease Control. Outbreaks of hepatitis B virus infection among hemodialysis patients, California, Nebraska, and Texas, 1994. MMWR 1996;45:285-9.
7. Bruguera M., Rodicio J.L., Alcazar J.M., Oliver A., Del Rio G., Esteban-Mur R. Effects of different dose levels and vaccination schedules on immune response to recombinant DNA hepatitis B vaccine in haemodialysis patients. Vaccine. 8(Suppl):1990;S47-S49
8. Propst T., Propst A., Lhotta K., Vogel W., Konig P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am. J. Kidney Dis. 32:1998;1041-1045
9. Rault R., Freed B., Nespor S., Bender F. Efficacy of different hepatitis B strategies in patients receiving hemodialysis. ASAIO J. 41:1995;717-719
10. Waite N.M., Thomson L.G., Goldstein M.B. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J. Am. Soc. Nephrol. 5:1995;1930-1934
11. Roll M., Norder H., Magnius L.O., Grillner L., Lindgren V. Nosocomial spread of hepatitis B virus (HBV) in a haemodialysis unit confirmed by HBV DNA sequencing. J. Hosp. Infect. 30:1995;57-63
12. Hauser P., Voet P., Simoen E., Thomas H.C., Petre J., De Wilde M., et al. Immunological properties of recombinant HBsAg produced in yeast. Postgrad. Med. J. 63(Suppl 2):1987;83-91
13. Bush L.M., Moonsammy G.I., Boscia J.A. Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another. Vaccine. 9(11):1991;807-809
14. Mitwalli A. Responsiveness to hepatitis B vaccine in immunocompromised patients by doubling the dose scheduling. Nephron. 73:1996;417-420
15. Stachowski J., Pollok M., Barth C., Maciejewski J., Baldamus C.A. Non-responsiveness to hepatitis B vaccination in haemodialysis patients: association with impaired TCR/CD3 antigen receptor expression regulating co-stimulatory processes in antigen presentation and recognition. Nephrol. Dial. Transplant. 9:1994;144-152
16. Bosnak M., Dikici B., Bosnak V., Haspolat K. Accelerated hepatitis B vaccination schedule in childhood. Pediatr. Int. 44(6):2002;663-665
17. Mauri J.M., Valles M. Effects of recombinant interleukin-2 and revaccination for hepatitis B in previously vaccinated, non-responder, chronic uraemic patients. Collaborative Group of Girona. Nephrol. Dial. Transplant. 12:1997;729-732
18. El-Reshaid K., Al-Mufti S., Johny K.V., Sugathan T.N. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients. Vaccine. 12:1994;223-228
19. Wood R.C., MacDonald K.L., White K.E., Hedberg C.W., Hanson M., Osterholm M.T. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. J. Am. Med. Assoc. 270(24):1993;2935-2939
20. Lewis-Ximenez L.L., Oliveira J.M., Mercadante L.A., De Castro L., Santa Catharina W., Stuver S., et al. Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection. Nephron. 87:2001;19-26
21. Peces R., De la Torre M., Alcazar R., Urra J.M. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in the hemodialysis patients. Am. J. Kidney Dis. 29:1997;239-245
22. Cheng CH, Huang CC, Leu ML, Chiang CYF, Wu MS, Lai PC. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection. Vaccine 1997;15(12-13):1353-7.
23. Navarro J.F., Teruel J.L., Mateos M.L., Marcen R., Ortuno J. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection. Am. J. Nephrol. 16:1996;95-97
24. Swan A.M., DeVita M.V. Higher response rate to hepatitis B vaccination observed in chronic hemodialysis patients. Clin. Nephrol. 47(3):1997;207-208
25. Radovic M.M., Ostric V., Djukanovic L. Complete seroconversion after vaccination against hepatitis B virus in hemodialysis patients. Clin. Nephrol. 47(3):1997;206
26. Kroes A.C., van Bommel E.F., Kluytmans J.A., Weimar W. Hepatitis B and hemodialysis: the impact of universal precautions in preventing the transmission of bloodborne viruses. Infect. Control Hosp. Epidemiol. 19(7):1998;508-510
27. Ozener I.C., Koc M., Akoglu E. SAPD ve HD Hastalarinda Hepatit B Aşisina Antikor Yanitlarinin Karşilaştirilmasi Dicle Tip Dergisi. 26(4):2001;45-55
28. Oguz Y., Doganci L., Vural A. Seroconversion rates of two different doses of hepatitis B vaccine in Turkish haemodialysis patients. Cent. Eur. J. Public Health. 9:2001;44-45
29. Ohkawa K., Hayashi N., Yuki N., Masuzawa M., Kato M., Yamamoto K., et al. Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses. J. Med. Virol. 46(3):1995;258-264
30. Sennesael J.J., Van der Niepen P., Verbeelen D.L. Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int. 40(1):1991;121-128
31. Fernandez E., Betriu M.A., Gomez R., Montoliu J. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol. Dial. Transplant. 11:1996;1559-1563